This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Down -6.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Louisiana-Pacific (LPX)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Louisiana-Pacific (LPX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
LPXPositive Net Change
rsi stock-price-movement
Down -17.15% in 4 Weeks, Here's Why Aptiv (APTV) Looks Ripe for a Turnaround
by Zacks Equity Research
Aptiv (APTV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
APTVNegative Net Change
rsi stock-price-movement
Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Haemonetics (HAE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
HAEPositive Net Change
rsi stock-price-movement
New Found Gold Corp. (NFGC) Loses -23.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
New Found Gold Corp. (NFGC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
NFGCNegative Net Change
rsi stock-price-movement
After Plunging -18.51% in 4 Weeks, Here's Why the Trend Might Reverse for Gitlab (GTLB)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Gitlab (GTLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
GTLBPositive Net Change
rsi stock-price-movement
Down -9.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Spartan Stores (SPTN)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Spartan Stores (SPTN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SPTNNegative Net Change
rsi stock-price-movement
Down -11.43% in 4 Weeks, Here's Why Pitney Bowes (PBI) Looks Ripe for a Turnaround
by Zacks Equity Research
Pitney Bowes (PBI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PBINegative Net Change
rsi stock-price-movement
After Plunging -24.59% in 4 Weeks, Here's Why the Trend Might Reverse for Alpha Teknova (TKNO)
by Zacks Equity Research
Alpha Teknova (TKNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
TKNOPositive Net Change
rsi stock-price-movement
After Plunging -13.18% in 4 Weeks, Here's Why the Trend Might Reverse for Nice (NICE)
by Zacks Equity Research
Nice (NICE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
NICENegative Net Change
rsi stock-price-movement
Down -6.69% in 4 Weeks, Here's Why You Should You Buy the Dip in Byrna Technologies (BYRN)
by Zacks Equity Research
Byrna Technologies (BYRN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
BYRNNegative Net Change
rsi stock-price-movement
Down -8.97% in 4 Weeks, Here's Why You Should You Buy the Dip in LifeStance Health (LFST)
by Zacks Equity Research
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
LFSTNo Net Change
rsi stock-price-movement
Down -19.76% in 4 Weeks, Here's Why NanoX Imaging (NNOX) Looks Ripe for a Turnaround
by Zacks Equity Research
NanoX Imaging (NNOX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
NNOXNegative Net Change
rsi stock-price-movement
Con Ed (ED) Loses -6.18% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Con Ed (ED) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
EDNegative Net Change
rsi stock-price-movement
After Plunging -18.3% in 4 Weeks, Here's Why the Trend Might Reverse for Thermon Group (THR)
by Zacks Equity Research
Thermon Group (THR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
THRNegative Net Change
rsi stock-price-movement
Down -12.44% in 4 Weeks, Here's Why WPP (WPP) Looks Ripe for a Turnaround
by Zacks Equity Research
WPP (WPP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
WPPNegative Net Change
rsi stock-price-movement
After Plunging -27.95% in 4 Weeks, Here's Why the Trend Might Reverse for Cellectis (CLLS)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Cellectis (CLLS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CLLSNegative Net Change
rsi stock-price-movement
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA)
by Zacks Equity Research
Inventiva (IVA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
IVAPositive Net Change
rsi stock-price-movement
Down -7.86% in 4 Weeks, Here's Why You Should You Buy the Dip in Hess (HES)
by Zacks Equity Research
Hess (HES) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
HESNegative Net Change
rsi stock-price-movement
Passage Bio (PASG) Loses -22.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Passage Bio (PASG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PASGPositive Net Change
rsi stock-price-movement
After Plunging -10.68% in 4 Weeks, Here's Why the Trend Might Reverse for Alight (ALIT)
by Zacks Equity Research
Alight (ALIT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ALITPositive Net Change
rsi stock-price-movement
Down -12.75% in 4 Weeks, Here's Why You Should You Buy the Dip in BorgWarner (BWA)
by Zacks Equity Research
BorgWarner (BWA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
BWANegative Net Change
rsi stock-price-movement
After Plunging -11.36% in 4 Weeks, Here's Why the Trend Might Reverse for Matterport (MTTR)
by Zacks Equity Research
Matterport (MTTR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
MTTRNo Net Change
rsi stock-price-movement
Down -11.62% in 4 Weeks, Here's Why Banco Santander (SAN) Looks Ripe for a Turnaround
by Zacks Equity Research
Banco Santander (SAN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SANNegative Net Change
rsi stock-price-movement
Down -20.94% in 4 Weeks, Here's Why EverQuote (EVER) Looks Ripe for a Turnaround
by Zacks Equity Research
EverQuote (EVER) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
EVERPositive Net Change
rsi stock-price-movement
Down -14.08% in 4 Weeks, Here's Why ProAssurance (PRA) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for ProAssurance (PRA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PRANegative Net Change
rsi stock-price-movement